nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.458	1	CbGbCtD
Rasagiline—Wrist drop—Riluzole—amyotrophic lateral sclerosis	0.0383	0.0958	CcSEcCtD
Rasagiline—Radial nerve palsy—Riluzole—amyotrophic lateral sclerosis	0.0383	0.0958	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—ALS2—amyotrophic lateral sclerosis	0.012	0.0867	CbGpPWpGaD
Rasagiline—Vestibular disorder—Riluzole—amyotrophic lateral sclerosis	0.00912	0.0228	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—NEFH—amyotrophic lateral sclerosis	0.00909	0.0657	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—PRPH—amyotrophic lateral sclerosis	0.00909	0.0657	CbGpPWpGaD
Rasagiline—Psychotic depression—Riluzole—amyotrophic lateral sclerosis	0.00874	0.0219	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—NEFM—amyotrophic lateral sclerosis	0.00773	0.0559	CbGpPWpGaD
Rasagiline—Major depression—Riluzole—amyotrophic lateral sclerosis	0.0068	0.017	CcSEcCtD
Rasagiline—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00576	0.0144	CcSEcCtD
Rasagiline—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.00562	0.0141	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—GABARAPL2—amyotrophic lateral sclerosis	0.00532	0.0384	CbGpPWpGaD
Rasagiline—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00513	0.0128	CcSEcCtD
Rasagiline—Osteonecrosis—Riluzole—amyotrophic lateral sclerosis	0.00492	0.0123	CcSEcCtD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.0049	0.0354	CbGpPWpGaD
Rasagiline—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0116	CcSEcCtD
Rasagiline—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0112	CcSEcCtD
Rasagiline—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00446	0.0112	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—CASP12—amyotrophic lateral sclerosis	0.00444	0.0321	CbGpPWpGaD
Rasagiline—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0108	CcSEcCtD
Rasagiline—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00423	0.0106	CcSEcCtD
Rasagiline—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00978	CcSEcCtD
Rasagiline—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00978	CcSEcCtD
Rasagiline—MAOB—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00383	0.0276	CbGpPWpGaD
Rasagiline—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00949	CcSEcCtD
Rasagiline—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00949	CcSEcCtD
Rasagiline—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00922	CcSEcCtD
Rasagiline—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00909	CcSEcCtD
Rasagiline—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00909	CcSEcCtD
Rasagiline—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00909	CcSEcCtD
Rasagiline—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00348	0.00872	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—SLC1A2—amyotrophic lateral sclerosis	0.00337	0.0243	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—RAB5A—amyotrophic lateral sclerosis	0.00337	0.0243	CbGpPWpGaD
Rasagiline—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00839	CcSEcCtD
Rasagiline—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00828	CcSEcCtD
Rasagiline—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00828	CcSEcCtD
Rasagiline—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00808	CcSEcCtD
Rasagiline—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00789	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—NEFL—amyotrophic lateral sclerosis	0.00308	0.0222	CbGpPWpGaD
Rasagiline—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00762	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.00302	0.0218	CbGpPWpGaD
Rasagiline—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00754	CcSEcCtD
Rasagiline—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00754	CcSEcCtD
Rasagiline—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00745	CcSEcCtD
Rasagiline—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00291	0.0073	CcSEcCtD
Rasagiline—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00279	0.007	CcSEcCtD
Rasagiline—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00686	CcSEcCtD
Rasagiline—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00673	CcSEcCtD
Rasagiline—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00673	CcSEcCtD
Rasagiline—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00264	0.0066	CcSEcCtD
Rasagiline—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00648	CcSEcCtD
Rasagiline—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00648	CcSEcCtD
Rasagiline—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00642	CcSEcCtD
Rasagiline—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00636	CcSEcCtD
Rasagiline—Mania—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00631	CcSEcCtD
Rasagiline—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00614	CcSEcCtD
Rasagiline—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00614	CcSEcCtD
Rasagiline—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00609	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—CST3—amyotrophic lateral sclerosis	0.00242	0.0174	CbGpPWpGaD
Rasagiline—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00599	CcSEcCtD
Rasagiline—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00599	CcSEcCtD
Rasagiline—BCL2—IL-5 Signaling Pathway—MAPT—amyotrophic lateral sclerosis	0.00239	0.0173	CbGpPWpGaD
Rasagiline—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00589	CcSEcCtD
Rasagiline—BCL2—IL-2 Signaling Pathway—MAPT—amyotrophic lateral sclerosis	0.0023	0.0166	CbGpPWpGaD
Rasagiline—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00228	0.0057	CcSEcCtD
Rasagiline—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00566	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—CASP12—amyotrophic lateral sclerosis	0.00219	0.0158	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—ECE1—amyotrophic lateral sclerosis	0.00219	0.0158	CbGpPWpGaD
Rasagiline—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00541	CcSEcCtD
Rasagiline—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00533	CcSEcCtD
Rasagiline—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00522	CcSEcCtD
Rasagiline—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00518	CcSEcCtD
Rasagiline—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00508	CcSEcCtD
Rasagiline—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00504	CcSEcCtD
Rasagiline—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.002	0.00501	CcSEcCtD
Rasagiline—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00494	CcSEcCtD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP9—amyotrophic lateral sclerosis	0.00197	0.0142	CbGpPWpGaD
Rasagiline—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00485	CcSEcCtD
Rasagiline—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0047	CcSEcCtD
Rasagiline—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00467	CcSEcCtD
Rasagiline—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00464	CcSEcCtD
Rasagiline—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00459	CcSEcCtD
Rasagiline—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00453	CcSEcCtD
Rasagiline—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00448	CcSEcCtD
Rasagiline—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00443	CcSEcCtD
Rasagiline—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00443	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—CASP9—amyotrophic lateral sclerosis	0.00176	0.0127	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—CASP9—amyotrophic lateral sclerosis	0.00176	0.0127	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00175	0.0126	CbGpPWpGaD
Rasagiline—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00431	CcSEcCtD
Rasagiline—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00421	CcSEcCtD
Rasagiline—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00415	CcSEcCtD
Rasagiline—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00415	CcSEcCtD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—ATF1—amyotrophic lateral sclerosis	0.00164	0.0118	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.00164	0.0118	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—CASP9—amyotrophic lateral sclerosis	0.00162	0.0117	CbGpPWpGaD
Rasagiline—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00402	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—SOD1—amyotrophic lateral sclerosis	0.00158	0.0114	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00156	0.0113	CbGpPWpGaD
Rasagiline—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00386	CcSEcCtD
Rasagiline—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00372	CcSEcCtD
Rasagiline—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00372	CcSEcCtD
Rasagiline—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0037	CcSEcCtD
Rasagiline—Injury—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00362	CcSEcCtD
Rasagiline—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00359	CcSEcCtD
Rasagiline—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00354	CcSEcCtD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP9—amyotrophic lateral sclerosis	0.00141	0.0102	CbGpPWpGaD
Rasagiline—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00353	CcSEcCtD
Rasagiline—BCL2—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.00139	0.01	CbGpPWpGaD
Rasagiline—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00345	CcSEcCtD
Rasagiline—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00342	CcSEcCtD
Rasagiline—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00341	CcSEcCtD
Rasagiline—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00333	CcSEcCtD
Rasagiline—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00333	CcSEcCtD
Rasagiline—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00333	CcSEcCtD
Rasagiline—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00132	0.0033	CcSEcCtD
Rasagiline—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00131	0.00949	CbGpPWpGaD
Rasagiline—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00328	CcSEcCtD
Rasagiline—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00328	CcSEcCtD
Rasagiline—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00325	CcSEcCtD
Rasagiline—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00321	CcSEcCtD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—CASP9—amyotrophic lateral sclerosis	0.00127	0.00917	CbGpPWpGaD
Rasagiline—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00317	CcSEcCtD
Rasagiline—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00315	CcSEcCtD
Rasagiline—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00313	CcSEcCtD
Rasagiline—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00307	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00122	0.00881	CbGpPWpGaD
Rasagiline—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00304	CcSEcCtD
Rasagiline—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00294	CcSEcCtD
Rasagiline—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00288	CcSEcCtD
Rasagiline—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00288	CcSEcCtD
Rasagiline—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00288	CcSEcCtD
Rasagiline—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0028	CcSEcCtD
Rasagiline—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00269	CcSEcCtD
Rasagiline—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00266	CcSEcCtD
Rasagiline—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00265	CcSEcCtD
Rasagiline—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00263	CcSEcCtD
Rasagiline—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0026	CcSEcCtD
Rasagiline—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00257	CcSEcCtD
Rasagiline—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00257	CcSEcCtD
Rasagiline—Depression—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00256	CcSEcCtD
Rasagiline—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00253	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IGFBP3—amyotrophic lateral sclerosis	0.00101	0.00728	CbGpPWpGaD
Rasagiline—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.001	0.00251	CcSEcCtD
Rasagiline—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.001	0.00251	CcSEcCtD
Rasagiline—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000998	0.0025	CcSEcCtD
Rasagiline—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000998	0.0025	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000995	0.00719	CbGpPWpGaD
Rasagiline—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000982	0.00246	CcSEcCtD
Rasagiline—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000977	0.00245	CcSEcCtD
Rasagiline—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000966	0.00242	CcSEcCtD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000943	0.00681	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP9—amyotrophic lateral sclerosis	0.000931	0.00673	CbGpPWpGaD
Rasagiline—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000924	0.00231	CcSEcCtD
Rasagiline—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000922	0.00231	CcSEcCtD
Rasagiline—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000919	0.0023	CcSEcCtD
Rasagiline—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000915	0.00229	CcSEcCtD
Rasagiline—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000915	0.00229	CcSEcCtD
Rasagiline—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.000908	0.00227	CcSEcCtD
Rasagiline—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.000906	0.00227	CcSEcCtD
Rasagiline—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000904	0.00226	CcSEcCtD
Rasagiline—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.000901	0.00226	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CASP9—amyotrophic lateral sclerosis	0.000873	0.00631	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—SQSTM1—amyotrophic lateral sclerosis	0.000872	0.0063	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CASP9—amyotrophic lateral sclerosis	0.000866	0.00625	CbGpPWpGaD
Rasagiline—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000859	0.00215	CcSEcCtD
Rasagiline—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000853	0.00214	CcSEcCtD
Rasagiline—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000834	0.00209	CcSEcCtD
Rasagiline—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00083	0.00208	CcSEcCtD
Rasagiline—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00208	CcSEcCtD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—amyotrophic lateral sclerosis	0.000828	0.00598	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—TP53—amyotrophic lateral sclerosis	0.000826	0.00596	CbGpPWpGaD
Rasagiline—Chills—Riluzole—amyotrophic lateral sclerosis	0.000825	0.00207	CcSEcCtD
Rasagiline—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000812	0.00203	CcSEcCtD
Rasagiline—BCL2—Apoptosis—MAPT—amyotrophic lateral sclerosis	0.000809	0.00584	CbGpPWpGaD
Rasagiline—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000806	0.00202	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—IGFBP3—amyotrophic lateral sclerosis	0.000801	0.00579	CbGpPWpGaD
Rasagiline—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0008	0.002	CcSEcCtD
Rasagiline—BCL2—Ceramide signaling pathway—IGF1—amyotrophic lateral sclerosis	0.000797	0.00576	CbGpPWpGaD
Rasagiline—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000789	0.00198	CcSEcCtD
Rasagiline—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000784	0.00196	CcSEcCtD
Rasagiline—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000774	0.00194	CcSEcCtD
Rasagiline—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00077	0.00193	CcSEcCtD
Rasagiline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00075	0.00188	CcSEcCtD
Rasagiline—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000743	0.00186	CcSEcCtD
Rasagiline—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00074	0.00185	CcSEcCtD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—CASP3—amyotrophic lateral sclerosis	0.00074	0.00534	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—CASP3—amyotrophic lateral sclerosis	0.00074	0.00534	CbGpPWpGaD
Rasagiline—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000736	0.00184	CcSEcCtD
Rasagiline—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000722	0.00181	CcSEcCtD
Rasagiline—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000719	0.0018	CcSEcCtD
Rasagiline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000718	0.0018	CcSEcCtD
Rasagiline—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000716	0.00179	CcSEcCtD
Rasagiline—MAOB—nerve—amyotrophic lateral sclerosis	0.000715	0.181	CbGeAlD
Rasagiline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000703	0.00176	CcSEcCtD
Rasagiline—Cough—Riluzole—amyotrophic lateral sclerosis	0.000698	0.00175	CcSEcCtD
Rasagiline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000693	0.00174	CcSEcCtD
Rasagiline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000691	0.00173	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000684	0.00494	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—CASP3—amyotrophic lateral sclerosis	0.000683	0.00493	CbGpPWpGaD
Rasagiline—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000681	0.00171	CcSEcCtD
Rasagiline—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000681	0.00171	CcSEcCtD
Rasagiline—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000679	0.0017	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000677	0.00169	CcSEcCtD
Rasagiline—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000673	0.00169	CcSEcCtD
Rasagiline—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00167	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000664	0.00479	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—TP53—amyotrophic lateral sclerosis	0.000663	0.00479	CbGpPWpGaD
Rasagiline—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000659	0.00165	CcSEcCtD
Rasagiline—BCL2—Integrated Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000658	0.00475	CbGpPWpGaD
Rasagiline—Infection—Riluzole—amyotrophic lateral sclerosis	0.000649	0.00163	CcSEcCtD
Rasagiline—Shock—Riluzole—amyotrophic lateral sclerosis	0.000643	0.00161	CcSEcCtD
Rasagiline—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000641	0.0016	CcSEcCtD
Rasagiline—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000634	0.00159	CcSEcCtD
Rasagiline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000631	0.00158	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000625	0.00451	CbGpPWpGaD
Rasagiline—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000623	0.00156	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000612	0.00442	CbGpPWpGaD
Rasagiline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00061	0.00153	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000595	0.00149	CcSEcCtD
Rasagiline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000591	0.00148	CcSEcCtD
Rasagiline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000587	0.00147	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000582	0.00421	CbGpPWpGaD
Rasagiline—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000582	0.00146	CcSEcCtD
Rasagiline—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000581	0.00145	CcSEcCtD
Rasagiline—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000575	0.00144	CcSEcCtD
Rasagiline—BCL2—Apoptosis—CASP9—amyotrophic lateral sclerosis	0.00057	0.00412	CbGpPWpGaD
Rasagiline—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000568	0.00142	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000564	0.00141	CcSEcCtD
Rasagiline—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000559	0.0014	CcSEcCtD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000558	0.00403	CbGpPWpGaD
Rasagiline—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000538	0.00135	CcSEcCtD
Rasagiline—MAOB—hindbrain—amyotrophic lateral sclerosis	0.000536	0.136	CbGeAlD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000535	0.00386	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000534	0.00134	CcSEcCtD
Rasagiline—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000519	0.0013	CcSEcCtD
Rasagiline—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000516	0.00129	CcSEcCtD
Rasagiline—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000516	0.00129	CcSEcCtD
Rasagiline—BCL2—Apoptosis—IGF1—amyotrophic lateral sclerosis	0.000509	0.00368	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000483	0.00349	CbGpPWpGaD
Rasagiline—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000481	0.00121	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—amyotrophic lateral sclerosis	0.000474	0.00343	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—amyotrophic lateral sclerosis	0.000474	0.00343	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000473	0.00342	CbGpPWpGaD
Rasagiline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000469	0.00117	CcSEcCtD
Rasagiline—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000462	0.00116	CcSEcCtD
Rasagiline—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00112	CcSEcCtD
Rasagiline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000432	0.00108	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IGF1—amyotrophic lateral sclerosis	0.000426	0.00308	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—PTGS2—amyotrophic lateral sclerosis	0.000422	0.00305	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000422	0.00305	CbGpPWpGaD
Rasagiline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000415	0.00104	CcSEcCtD
Rasagiline—Rash—Riluzole—amyotrophic lateral sclerosis	0.000412	0.00103	CcSEcCtD
Rasagiline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00103	CcSEcCtD
Rasagiline—Headache—Riluzole—amyotrophic lateral sclerosis	0.000409	0.00102	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000407	0.00294	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000392	0.00283	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000388	0.00281	CbGpPWpGaD
Rasagiline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000388	0.000972	CcSEcCtD
Rasagiline—BCL2—nervous system—amyotrophic lateral sclerosis	0.000386	0.098	CbGeAlD
Rasagiline—BCL2—central nervous system—amyotrophic lateral sclerosis	0.000372	0.0944	CbGeAlD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CASP3—amyotrophic lateral sclerosis	0.000368	0.00266	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.000365	0.00263	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000363	0.00262	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000363	0.00262	CbGpPWpGaD
Rasagiline—BCL2—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000345	0.00249	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000344	0.00248	CbGpPWpGaD
Rasagiline—MAOB—embryo—amyotrophic lateral sclerosis	0.000335	0.085	CbGeAlD
Rasagiline—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000332	0.00239	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000308	0.00223	CbGpPWpGaD
Rasagiline—MAOB—brainstem—amyotrophic lateral sclerosis	0.000307	0.0779	CbGeAlD
Rasagiline—BCL2—brain—amyotrophic lateral sclerosis	0.000295	0.0749	CbGeAlD
Rasagiline—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00029	0.00209	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00027	0.00195	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—IGF1—amyotrophic lateral sclerosis	0.000265	0.00192	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000264	0.00191	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000262	0.00189	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000251	0.00182	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000245	0.00177	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000245	0.00177	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.00024	0.00174	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—amyotrophic lateral sclerosis	0.000236	0.0017	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000219	0.00158	CbGpPWpGaD
Rasagiline—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.000214	0.0543	CbGeAlD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—amyotrophic lateral sclerosis	0.00021	0.00152	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000209	0.00151	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000208	0.0015	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—amyotrophic lateral sclerosis	0.000204	0.00147	CbGpPWpGaD
Rasagiline—BCL2—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000203	0.00147	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000203	0.00147	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000199	0.00144	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000199	0.00143	CbGpPWpGaD
Rasagiline—MAOB—spinal cord—amyotrophic lateral sclerosis	0.000191	0.0484	CbGeAlD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000188	0.00136	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000187	0.00135	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000183	0.00132	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—VEGFA—amyotrophic lateral sclerosis	0.000173	0.00125	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000172	0.00125	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000172	0.00124	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000171	0.00123	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—amyotrophic lateral sclerosis	0.000167	0.00121	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000163	0.00118	CbGpPWpGaD
Rasagiline—MAOB—nervous system—amyotrophic lateral sclerosis	0.000161	0.0408	CbGeAlD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00016	0.00116	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000157	0.00114	CbGpPWpGaD
Rasagiline—MAOB—central nervous system—amyotrophic lateral sclerosis	0.000155	0.0393	CbGeAlD
Rasagiline—BCL2—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000154	0.00111	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000152	0.0011	CbGpPWpGaD
Rasagiline—MAOB—cerebellum—amyotrophic lateral sclerosis	0.000151	0.0384	CbGeAlD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000151	0.00109	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000151	0.00109	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000142	0.00102	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00013	0.000941	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.00013	0.000939	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000128	0.000927	CbGpPWpGaD
Rasagiline—MAOB—brain—amyotrophic lateral sclerosis	0.000123	0.0312	CbGeAlD
Rasagiline—BCL2—Immune System—ATF1—amyotrophic lateral sclerosis	0.000122	0.00088	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CASP9—amyotrophic lateral sclerosis	0.000116	0.000838	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000109	0.000791	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000108	0.00078	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000103	0.000746	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ERBB4—amyotrophic lateral sclerosis	9.94e-05	0.000718	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD40LG—amyotrophic lateral sclerosis	9.34e-05	0.000675	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	8.39e-05	0.000606	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	8.39e-05	0.000606	CbGpPWpGaD
Rasagiline—BCL2—Immune System—C3—amyotrophic lateral sclerosis	8.26e-05	0.000596	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.09e-05	0.000584	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	7.82e-05	0.000565	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	7.67e-05	0.000554	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.44e-05	0.000537	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.13e-05	0.000515	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	6.71e-05	0.000484	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	6.12e-05	0.000442	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	6.07e-05	0.000438	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	4.6e-05	0.000332	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	4.24e-05	0.000306	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.19e-05	0.000303	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.86e-05	0.000279	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.48e-05	0.000252	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.18e-05	0.00023	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.18e-05	0.000157	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.87e-05	0.000135	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.72e-05	0.000124	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.42e-05	0.000102	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.7e-06	7.01e-05	CbGpPWpGaD
